The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality ResultsSAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare ...

Labcorp Holdings ( ($LH) ) has issued an update. On December 30, 2025, Labcorp announced it would participate in a fireside chat at the 44th ...

Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...